Genmab A/S ADR (GMAB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2019 | 03-2019 | 12-2018 | |
| Cash Flows From Operating Activities | |||
| Net Income | 30,805 | N/A | 255,336 |
| Depreciation Amortization | N/A | N/A | 13,875 |
| Other Working Capital | 105,408 | N/A | -100,485 |
| Other Operating Activity | -10,910 | 0 | -7,984 |
| Operating Cash Flow | $125,303 | $N/A | $160,742 |
| Cash Flows From Investing Activities | |||
| Change In Deposits | -113,027 | N/A | N/A |
| PPE Investments | N/A | N/A | -11,356 |
| Purchase Sale Intangibles | -5,357 | N/A | N/A |
| Other Investing Activity | -5,357 | 0 | -270,208 |
| Investing Cash Flow | $-118,384 | $N/A | $-281,564 |
| Cash Flows From Financing Activities | |||
| Common Stock Issued | 5,824 | N/A | N/A |
| Other Financing Activity | -3,472 | 0 | -11,231 |
| Financing Cash Flow | $2,352 | $N/A | $-11,231 |
| Exchange Rate Effect | -1,748 | N/A | 3,014 |
| Beginning Cash Position | 80,256 | N/A | 213,451 |
| End Cash Position | 87,779 | N/A | 84,412 |
| Net Cash Flow | $7,523 | $N/A | $-129,039 |
| Free Cash Flow | |||
| Operating Cash Flow | 125,303 | N/A | 160,742 |
| Free Cash Flow | 125,303 | 0 | 160,742 |